The TARGET BP I Trial is a randomized, blinded, multi-center, international, sham-procedure
controlled trial, comparing renal denervation performed with the Peregrine System Kit in the
treatment group to the sham control group (without renal denervation - no alcohol infusion).
Subjects will be randomized in a 1:1 fashion to treatment versus sham control via central
randomization.